Cholinesterase inhibitors improve survival in experimental sepsis: a new way to activate the cholinergic anti-inflammatory pathway.
Fodale
Vincenzo
V
Santamaria
Letterio B
LB
D000818:Animals; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D016207:Cytokines / Q000502:physiology; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D051379:Mice; D010830:Physostigmine / Q000627:therapeutic use*; D011950:Receptors, Cholinergic / Q000502:physiology; D018805:Sepsis / Q000188:drug therapy*
D002800:Cholinesterase Inhibitors; D016207:Cytokines; D018836:Inflammation Mediators; D011950:Receptors, Cholinergic; D010830:Physostigmine